RGNX EPS Estimates
REGENXBIO Inc.
$6.88
-$0.38(-5.23%)
42
Overall
40
Value
40
Tech
47
Quality
Market Cap
$454.17M
Volume
1.57M
52W Range
$5.46 - $16.19
Target Price
$24.23
RGNX EPS estimates: the consensus estimate for REGENXBIO Inc.'s current fiscal year is -$3.80 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RGNX EPS Estimates
- EPS estimate, current quarter
- $-1.36
- EPS estimate, next quarter
- $-0.80
- EPS estimate, current year
- $-3.80
- EPS estimate, next year
- $-3.08
- EPS growth, 3-year
- +16.68%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.76 |
| 2024 | $-4.59 |
| 2023 | $-6.02 |
| 2022 | $-6.50 |
| 2021 | $3.01 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RGNX | $6.88 | -5.2% | 1.57M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |